Insulin-producing cells injected into a man with type 1 diabetes have survived for a month so far without the need for immune ...

In type 2 diabetes, the body's ability to release insulin is impaired, which leads to high blood glucose levels. Research led ...

After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and type 1 diabetes.

Sana Biotechnology has shared early data for its investigational allogeneic cell therapy being studied in one patient with ...

Diabetes has long been lumped into two categories—type 1, which often appears in childhood, or type 2, which is associated ...

Sana Biotechnology's first-in-human study shows UP421 pancreatic islet cells surviving and functioning in type 1 diabetes ...

“In type 1 diabetes, a person’s immune system attacks and destroys the beta cells. Today’s data, when combined with progress elsewhere in the field, provide real hope that a ...

Sana Biotechnology (SANA) announced initial results from an investigator-sponsored, first-in-human study transplanting UP421, an allogeneic ...

Chronic exposure to hyperglycemia can lead to cellular dysfunction that may become irreversible over time, a process that is termed glucose toxicity. Our perspective about glucose toxicity as it ...

Sana stock soars in a week following positive initial data from a first-in-human study of investigational cell therapy, UP421, in diabetes patients.